{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:24:18Z","timestamp":1793982258879,"version":"4.8.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11010-021-04294-z","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T02:02:57Z","timestamp":1637028177000},"page":"479-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["The role of endoglin and its soluble form in pathogenesis of preeclampsia"],"prefix":"10.1007","volume":"477","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2337-6484","authenticated-orcid":false,"given":"Georgia","family":"Margioula-Siarkou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysoula","family":"Margioula-Siarkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatios","family":"Petousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosmas","family":"Margaritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Vavoulidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Alexandratou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Sotiriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Mavromatidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"issue":"1","key":"4294_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/AOG.0000000000003018","volume":"133","author":"Committee on Practice Bulletins\u2014Obstetrics","year":"2019","unstructured":"Committee on Practice Bulletins\u2014Obstetrics (2019) ACOG practice bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol 133(1):1. https:\/\/doi.org\/10.1097\/AOG.0000000000003018","journal-title":"Obstet Gynecol"},{"issue":"5","key":"4294_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/ajo.12399","volume":"55","author":"SA Lowe","year":"2015","unstructured":"Lowe SA, Bowyer L, Lust K, McMahon LP, Morton M, North RA, Paech M, Said JM (2015) SOMANZ guidelines for the management of hypertensive disorders of pregnancy. Aust New Zeal J Obstet Gynaecol 55(5):e1-29. https:\/\/doi.org\/10.1111\/ajo.12399","journal-title":"Aust New Zeal J Obstet Gynaecol"},{"issue":"5","key":"4294_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/s1701-2163(15)30588-0","volume":"36","author":"LA Magee","year":"2014","unstructured":"Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Canadian Hypertensive Disorders of Pregnancy Working Group (2014) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Canada 36(5):416\u2013441. https:\/\/doi.org\/10.1016\/s1701-2163(15)30588-0","journal-title":"J Obstet Gynaecol Canada"},{"key":"4294_CR4","volume-title":"The FIGO Textbook of pregnancy hypertension: an evidence-based guide to monitoring, prevention and management","author":"LA Magee","year":"2016","unstructured":"Magee LA, von Dadelszen P, Stones W, Mathai M (2016) The FIGO Textbook of pregnancy hypertension: an evidence-based guide to monitoring, prevention and management. The Global Library of Women\u2019s Medicine, London"},{"issue":"10022","key":"4294_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BWJ Mol","year":"2016","unstructured":"Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, De Groot CJM, Hofmeyr GJ (2016) Pre-eclampsia. Lancet 387(10022):999\u20131011. https:\/\/doi.org\/10.1016\/S0140-6736(15)00070-7","journal-title":"Lancet"},{"issue":"Suppl 1","key":"4294_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D\u2019Alton M, Berghella V, Nicolaides KH, Hod M (2019) The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet 145(Suppl 1):1\u201333. https:\/\/doi.org\/10.1002\/ijgo.12802","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"4294_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1479-828X.2009.01003.x","volume":"77","author":"NICE","year":"2019","unstructured":"NICE (2019) Hypertension in pregnancy: diagnosis and management. Am J Obs Gynecol 77(1):S1-s22. https:\/\/doi.org\/10.1111\/j.1479-828X.2009.01003.x","journal-title":"Am J Obs Gynecol"},{"issue":"1","key":"4294_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","volume":"170","author":"E Abalos","year":"2013","unstructured":"Abalos E, Cuesta C, Grosso AL, Chou D, Say L (2013) Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 170(1):1\u20137. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.05.005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4294_CR9","doi-asserted-by":"publisher","first-page":"6268276","DOI":"10.1155\/2018\/6268276","volume":"2018","author":"J Mayrink","year":"2018","unstructured":"Mayrink J, Costa ML, Cecatti JG (2018) Preeclampsia in 2018: revisiting concepts, physiopathology, and prediction. Sci World J 2018:6268276. https:\/\/doi.org\/10.1155\/2018\/6268276","journal-title":"Sci World J"},{"issue":"6","key":"4294_CR10","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2215\/CJN.12081115","volume":"11","author":"E Phipps","year":"2016","unstructured":"Phipps E, Prasanna D, Brima W, Jim B (2016) Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol 11(6):1102\u20131113. https:\/\/doi.org\/10.2215\/CJN.12081115","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"4294_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana S, Lemoine E, Granger J, Karumanchi SA (2019) Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 124(7):1094\u20131112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313276","journal-title":"Circ Res"},{"issue":"2","key":"4294_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5830\/CVJA-2016-009","volume":"27","author":"P Gathiram","year":"2016","unstructured":"Gathiram P, Moodley J (2016) Pre-eclampsia: Its pathogenesis and pathophysiology. Cardiovasc J Afr 27(2):71\u201378. https:\/\/doi.org\/10.5830\/CVJA-2016-009","journal-title":"Cardiovasc J Afr"},{"issue":"7","key":"4294_CR13","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1172\/JCI70431","volume":"123","author":"R Romero","year":"2013","unstructured":"Romero R, Chaiworapongsa T (2013) Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state. J Clin Invest 123(7):2775\u20132777. https:\/\/doi.org\/10.1172\/JCI70431","journal-title":"J Clin Invest"},{"issue":"6","key":"4294_CR14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.116.06421","volume":"67","author":"SA Karumanchi","year":"2016","unstructured":"Karumanchi SA (2016) Angiogenic factors in preeclampsia: from diagnosis to therapy. Hypertension 67(6):1072\u20131079. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.06421","journal-title":"Hypertension"},{"issue":"3","key":"4294_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/apha.12106","volume":"208","author":"AC Palei","year":"2013","unstructured":"Palei AC, Spradley FT, Warrington JP, George EM, Granger JP (2013) Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol 208(3):224\u2013233. https:\/\/doi.org\/10.1111\/apha.12106","journal-title":"Acta Physiol"},{"issue":"2","key":"4294_CR16","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.134.2.1276","volume":"134","author":"EJ Quackenbush","year":"1985","unstructured":"Quackenbush EJ, Letarte M (1985) Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J Immunol 134(2):1276\u20131285","journal-title":"J Immunol"},{"issue":"15","key":"4294_CR17","doi-asserted-by":"publisher","first-page":"8361","DOI":"10.1016\/S0021-9258(19)38892-1","volume":"265","author":"A Gougos","year":"1990","unstructured":"Gougos A, Letarte M (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265(15):8361\u20138364","journal-title":"J Biol Chem"},{"issue":"Pt 6","key":"4294_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1242\/jcs.023283","volume":"121","author":"S Velasco","year":"2008","unstructured":"Velasco S, Alvarez-Munoz P, Pericacho M, Ten Dijke P, Bernabeu C, Lopez-Novoa JM, Rodriguez-Barbero A (2008) L- and S-endoglin differentially modulate TGF\u03b21 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts. J Cell Sci 121(Pt 6):913\u2013919. https:\/\/doi.org\/10.1242\/jcs.023283","journal-title":"J Cell Sci"},{"issue":"1","key":"4294_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1086\/513906","volume":"61","author":"CL Shovlin","year":"1997","unstructured":"Shovlin CL, Hughes JMB, Scott J, Seidman CE, Seidman JG (1997) Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61(1):68\u201379. https:\/\/doi.org\/10.1086\/513906","journal-title":"Am J Hum Genet"},{"issue":"1","key":"4294_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10456-008-9101-9","volume":"11","author":"P Ten Dijke","year":"2008","unstructured":"Ten Dijke P, Goumans MJ, Pardali E (2008) Endoglin in angiogenesis and vascular diseases. Angiogenesis 11(1):79\u201389. https:\/\/doi.org\/10.1007\/s10456-008-9101-9","journal-title":"Angiogenesis"},{"issue":"46","key":"4294_CR21","doi-asserted-by":"publisher","first-page":"43799","DOI":"10.1074\/jbc.M207160200","volume":"277","author":"T S\u00e1nchez-Elsner","year":"2002","unstructured":"S\u00e1nchez-Elsner T, Botella LM, Velasco B, Langa C, Bernab\u00e9u C (2002) Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-\u03b2 pathways. J Biol Chem 277(46):43799\u201343808. https:\/\/doi.org\/10.1074\/jbc.M207160200","journal-title":"J Biol Chem"},{"issue":"6","key":"4294_CR22","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1095\/biolreprod.107.066498","volume":"78","author":"J Henry-Berger","year":"2008","unstructured":"Henry-Berger J, Mouzat K, Baron S, Bernabeu C, Marceau G, Saru JP, Lobaccaro JMA, Caira F (2008) Endoglin (CD105) expression is regulated by the liver X receptor alpha (NR1H3) in human trophoblast cell line JAR1. Biol Reprod 78(6):968\u2013975. https:\/\/doi.org\/10.1095\/biolreprod.107.066498","journal-title":"Biol Reprod"},{"issue":"8","key":"4294_CR23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.2174\/15665240113139990058","volume":"13","author":"B Oujo","year":"2013","unstructured":"Oujo B, Perez-Barriocanal F, Bernabeu C, Lopez-Novoa J (2013) Membrane and soluble forms of endoglin in preeclampsia. Curr Mol Med 13(8):1345\u20131357. https:\/\/doi.org\/10.2174\/15665240113139990058","journal-title":"Curr Mol Med"},{"issue":"1","key":"4294_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1479-5876-2-18","volume":"2","author":"E Fonsatti","year":"2004","unstructured":"Fonsatti E, Maio M (2004) Highlights on endoglin (CD105): from basic findings towards clinical applications in human cance. J Transl Med 2(1):18. https:\/\/doi.org\/10.1186\/1479-5876-2-18","journal-title":"J Transl Med"},{"issue":"6","key":"4294_CR25","first-page":"2283","volume":"31","author":"F Nassiri","year":"2011","unstructured":"Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM, Syro LV, Kovacs K, Lloyd RV (2011) Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 31(6):2283\u20132290","journal-title":"Anticancer Res"},{"issue":"6","key":"4294_CR26","doi-asserted-by":"publisher","first-page":"e100310","DOI":"10.1371\/journal.pone.0100310","volume":"9","author":"B Gore","year":"2014","unstructured":"Gore B, Iziki M, Mercier O, Dewachter L, Fadel E, Humbert M, Dartevelle P, Simonneau G, Naeije R, Lebrin F, Eddahibi S (2014) Key role of the endothelial TGF-\u03b2\/ALK1\/endoglin signaling pathway in humans and rodents pulmonary hypertension. PLoS ONE 9(6):e100310. https:\/\/doi.org\/10.1371\/journal.pone.0100310","journal-title":"PLoS ONE"},{"issue":"17","key":"4294_CR27","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1091\/mbc.E15-02-0069","volume":"26","author":"L Pomeraniec","year":"2015","unstructured":"Pomeraniec L, Hector-Greene M, Ehrlich M, Blobe GC, Henis YI (2015) Regulation of TGF-\u03b2 receptor hetero-oligomerization and signaling by endoglin. Mol Biol Cell 26(17):3117\u20133127. https:\/\/doi.org\/10.1091\/mbc.E15-02-0069","journal-title":"Mol Biol Cell"},{"key":"4294_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fphys.2011.00089","volume":"2","author":"M Valluru","year":"2011","unstructured":"Valluru M, Staton CA, Reed MWR, Brown NJ (2011) Transforming growth factor-\u03b2 and endoglin signaling orchestrate wound healing. Front Physiol 2:89. https:\/\/doi.org\/10.3389\/fphys.2011.00089","journal-title":"Front Physiol"},{"key":"4294_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1159\/000327776","volume":"48","author":"Y Tang","year":"2011","unstructured":"Tang Y, Yang X, Friesel RE, Vary CPH, Liaw L (2011) Mechanisms of TGF-\u03b2-induced differentiation in human vascular smooth muscle cells. J Vasc Res 48:485\u2013494. https:\/\/doi.org\/10.1159\/000327776","journal-title":"J Vasc Res"},{"issue":"3","key":"4294_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/carcin\/bgp327","volume":"31","author":"BN Ray","year":"2010","unstructured":"Ray BN, Lee NY, How T, Blobe GC (2010) ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1\/5\/8 signaling and endothelial cell migration. Carcinogenesi 31(3):435\u2013441. https:\/\/doi.org\/10.1093\/carcin\/bgp327","journal-title":"Carcinogenesi"},{"issue":"3","key":"4294_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/carcin\/bgp217","volume":"31","author":"D Romero","year":"2010","unstructured":"Romero D, Terzic A, Conley BA, Craft CS, Jovanovic B, Bergan RC, Vary CPH (2010) Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration. Carcinogenesis 31(3):359\u2013366. https:\/\/doi.org\/10.1093\/carcin\/bgp217","journal-title":"Carcinogenesis"},{"issue":"1","key":"4294_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2019.00010","volume":"6","author":"E Rossi","year":"2019","unstructured":"Rossi E, Bernabeu C, Smadja DM (2019) Endoglin as an adhesion molecule in mature and progenitor endothelial cells: a function beyond TGF-\u03b2. Front Med 6(1):1\u20138. https:\/\/doi.org\/10.3389\/fmed.2019.00010","journal-title":"Front Med"},{"key":"4294_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022210","author":"MJ Goumans","year":"2018","unstructured":"Goumans MJ, Dijke PT (2018) TGF-\u03b2 signaling in control of cardiovascular function. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a022210","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"4294_CR34","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3324\/HAEMATOL.2018.193003","volume":"103","author":"A Kritharis","year":"2018","unstructured":"Kritharis A, Al-Samkari H, Kuter DJ (2018) Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective. Haematologica 103(9):1433. https:\/\/doi.org\/10.3324\/HAEMATOL.2018.193003","journal-title":"Haematologica"},{"issue":"5","key":"4294_CR35","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1096\/fj.201802245R","volume":"33","author":"M Vicen","year":"2019","unstructured":"Vicen M, Vitverova B, Havelek R, Blazickova K, Machalek M, Rathouska J, Najmanova I, Dolezelova E, Prasnicka A, Sternak M, Bernabeu C, Nachtigal P (2019) Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro. FASEB J 33(5):6099\u20136114. https:\/\/doi.org\/10.1096\/fj.201802245R","journal-title":"FASEB J"},{"issue":"8","key":"4294_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00018-020-03701-W","volume":"78","author":"M Vicen","year":"2021","unstructured":"Vicen M, Igreja Sa IV, Tripska K, Vitverova B, Najmanova I, Eissazadeh S, Micuda S, Nachtigal P (2021) Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome. Cell Mol Life Sci 78(8):1\u201314. https:\/\/doi.org\/10.1007\/S00018-020-03701-W","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"4294_CR37","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1096\/FJ.14-269258","volume":"29","author":"M Jerkic","year":"2015","unstructured":"Jerkic M, Letarte M (2015) Increased endothelial cell permeability in endoglin-deficient cells. FASEB J 29(9):3678\u20133688. https:\/\/doi.org\/10.1096\/FJ.14-269258","journal-title":"FASEB J"},{"issue":"6","key":"4294_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/01.RES.0000159936.38601.22","volume":"96","author":"M Toporsian","year":"2005","unstructured":"Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M (2005) A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 96(6):684\u2013692. https:\/\/doi.org\/10.1161\/01.RES.0000159936.38601.22","journal-title":"Circ Res"},{"issue":"2","key":"4294_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom10020289","volume":"10","author":"MJA Schoonderwoerd","year":"2020","unstructured":"Schoonderwoerd MJA, Goumans MJTH, Hawinkels LJAC (2020) Endoglin: beyond the endothelium. Biomolecules 10(2):1\u201318. https:\/\/doi.org\/10.3390\/biom10020289","journal-title":"Biomolecules"},{"issue":"2","key":"4294_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1182\/BLOOD-2012-06-435347","volume":"121","author":"E Rossi","year":"2013","unstructured":"Rossi E, Sanz-Rodriguez F, Eleno N, Duwell A, Blanco FJ, Langa C, Botella LM, Cabanas C, Lopez-Novoa JM, Bernabeu C (2013) Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. Blood 121(2):403\u2013415. https:\/\/doi.org\/10.1182\/BLOOD-2012-06-435347","journal-title":"Blood"},{"issue":"1","key":"4294_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/J.ATHEROSCLEROSIS.2012.03.001","volume":"224","author":"P Nachtigal","year":"2012","unstructured":"Nachtigal P, Vecerova LZ, Rathouska J, Strasky Z (2012) The role of endoglin in atherosclerosis. Atherosclerosis 224(1):4\u201311. https:\/\/doi.org\/10.1016\/J.ATHEROSCLEROSIS.2012.03.001","journal-title":"Atherosclerosis"},{"issue":"5","key":"4294_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4110\/IN.2014.14.5.237","volume":"14","author":"YS Jang","year":"2014","unstructured":"Jang YS, Choi IH (2014) Contrasting roles of different endoglin forms in atherosclerosis. Immune Netw 14(5):237. https:\/\/doi.org\/10.4110\/IN.2014.14.5.237","journal-title":"Immune Netw"},{"issue":"45","key":"4294_CR43","doi-asserted-by":"publisher","first-page":"39497","DOI":"10.1074\/jbc.M111.256529","volume":"286","author":"B Levi","year":"2011","unstructured":"Levi B, Wan DC, Glotzbach JP, Hyun J, Januszyk M, Montoro D, Sorkin M, James AW, Nelson ER, Li S, Quarto N, Lee M, Gurtner GC, Longaker MT (2011) CD105 protein depletion enhances human adipose-derived stromal cell osteogenesis through reduction of transforming growth factor \u03b21 (TGF-\u03b21) signaling. J Biol Chem 286(45):39497\u201339509. https:\/\/doi.org\/10.1074\/jbc.M111.256529","journal-title":"J Biol Chem"},{"issue":"6","key":"4294_CR44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY (2016) TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol 12(6):325\u2013338. https:\/\/doi.org\/10.1038\/nrneph.2016.48","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"4294_CR45","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.24007","volume":"124","author":"K Fujita","year":"2009","unstructured":"Fujita K (2009) Endoglin (CD105) as a urinary and serum marker of prostate cancer. Int J Cancer 124(3):664\u2013669. https:\/\/doi.org\/10.1002\/ijc.24007","journal-title":"Int J Cancer"},{"issue":"12","key":"4294_CR46","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.3390\/ijms19123887","volume":"19","author":"A Kasprzak","year":"2018","unstructured":"Kasprzak A, Adamek A (2018) Role of endoglin (CD105) in the progression of hepatocellular carcinoma and anti-angiogenic therapy. Int J Mol Sci 19(12):3887. https:\/\/doi.org\/10.3390\/ijms19123887","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4294_CR47","first-page":"185","volume":"28","author":"L Perez","year":"2014","unstructured":"Perez L, Lopez JM (2014) Soluble endoglin: a biomarker or a protagonist in the pathogenesis of preeclampsia? Port JNephrol Hypertens 28(3):185\u2013192","journal-title":"Port JNephrol Hypertens"},{"key":"4294_CR48","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.placenta.2013.10.020","volume":"35","author":"AL Gregory","year":"2014","unstructured":"Gregory AL, Xu G, Sotov V, Letarte M (2014) Review: the enigmatic role of endoglin in the placenta. Placenta 35:S93-99. https:\/\/doi.org\/10.1016\/j.placenta.2013.10.020","journal-title":"Placenta"},{"issue":"10","key":"4294_CR49","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1158\/0008-5472.CAN-09-4466","volume":"70","author":"LJAC Hawinkels","year":"2010","unstructured":"Hawinkels LJAC, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, Sier CFM, ten Dijke P (2010) Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 70(10):4141\u20134150. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4466","journal-title":"Cancer Res"},{"issue":"6","key":"4294_CR50","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha S, Toporsian M, Lam C, Hanai JI, Mammoto T, Kim YM, Bdolah Y et al (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12(6):642\u2013649. https:\/\/doi.org\/10.1038\/nm1429","journal-title":"Nat Med"},{"issue":"36","key":"4294_CR51","doi-asserted-by":"publisher","first-page":"17800","DOI":"10.1073\/pnas.1816661116","volume":"116","author":"A Lawera","year":"2019","unstructured":"Lawera A, Tong Z, Thorikay M, Redgrave RE, Cai J, van Dinther M, Morrell NW, Afink GB, Charnock-Jones DS, Arthur HM, ten Dijke P, Li W (2019) Role of soluble endoglin in BMP9 signaling. Proc Natl Acad Sci U S A 116(36):17800\u201317808. https:\/\/doi.org\/10.1073\/pnas.1816661116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4294_CR52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.108.123513","volume":"53","author":"JS Gilbert","year":"2009","unstructured":"Gilbert JS, Gilbert SAB, Arany M, Granger JP (2009) Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 53(2):399\u2013403. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.123513","journal-title":"Hypertension"},{"issue":"13","key":"4294_CR53","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.106.660134","volume":"115","author":"M Cudmore","year":"2007","unstructured":"Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A (2007) Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115(13):1789\u20131797. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.660134","journal-title":"Circulation"},{"issue":"9","key":"4294_CR54","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.placenta.2014.06.374","volume":"35","author":"FC Brownfoot","year":"2014","unstructured":"Brownfoot FC, Hannan N, Onda K, Tong S, Kaitu\u2019U-Lino T (2014) Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells. Placenta 35(9):724\u2013731. https:\/\/doi.org\/10.1016\/j.placenta.2014.06.374","journal-title":"Placenta"},{"key":"4294_CR55","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cyto.2017.04.009","volume":"96","author":"C Margioula-Siarkou","year":"2017","unstructured":"Margioula-Siarkou C, Prapas Y, Petousis S, Milias S, Ravanos K, Dagklis T, Kalogiannidis I, Mavromatidis G, Haitoglu C, Prapas N, Rousso D (2017) LIF endometrial expression is impaired in women with unexplained infertility while LIF-R expression in all infertility sub-groups. Cytokine 96:166\u2013172. https:\/\/doi.org\/10.1016\/j.cyto.2017.04.009","journal-title":"Cytokine"},{"issue":"3","key":"4294_CR56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1530\/REP-17-0732","volume":"155","author":"H Li","year":"2018","unstructured":"Li H, Yao J, Chang X, Wu J, Duan T, Wang K (2018) LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia. Reproduction 155(3):297\u2013306. https:\/\/doi.org\/10.1530\/REP-17-0732","journal-title":"Reproduction"},{"issue":"6","key":"4294_CR57","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.3892\/mmr.2016.5142","volume":"13","author":"PY Margioula-Siarkou","year":"2016","unstructured":"Margioula-Siarkou PY, Petousis S, Milias S, Ravanos K, Kalogiannidis I, Mavromatidis G, Haitoglu C, Prapas N, Rousso D (2016) LIF and LIF-R expression in the endometrium of fertile and infertile women: a prospective observational case-control study. Mol Med Rep 13(6):4721\u20134728. https:\/\/doi.org\/10.3892\/mmr.2016.5142","journal-title":"Mol Med Rep"},{"issue":"23","key":"4294_CR58","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.3109\/14767058.2016.1144744","volume":"29","author":"X Liu","year":"2016","unstructured":"Liu X, Deng Q, Luo X, Chen Y, Shan N, Qi H (2016) Oxidative stress-induced Gadd45\u03b1 inhibits trophoblast invasion and increases sFlt1\/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia. J Matern Neonatal Med 29(23):3776\u20133785. https:\/\/doi.org\/10.3109\/14767058.2016.1144744","journal-title":"J Matern Neonatal Med"},{"issue":"5","key":"4294_CR59","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/HYPERTENSIONAHA.110.150540","volume":"55","author":"RA Irani","year":"2010","unstructured":"Irani RA, Zhang Y, Zho CC, Blackwell SC, Hicks MJ, Ramin SM, Kellems RE, Xia Y (2010) Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-\u03b1 signaling. Hypertension 55(5):1246\u20131253. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.150540","journal-title":"Hypertension"},{"issue":"1","key":"4294_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/IJMS22010165","volume":"22","author":"L P\u00e9rez-Roque","year":"2021","unstructured":"P\u00e9rez-Roque L, N\u00fa\u00f1ez-G\u00f3mez E, Rodr\u00edguez-Barbero A, Bernab\u00e9u C, L\u00f3pez-Novoa JM, Pericacho M (2021) Pregnancy-induced high plasma levels of soluble endoglin in mice lead to preeclampsia symptoms and placental abnormalities. Int J Mol Sci 22(1):165. https:\/\/doi.org\/10.3390\/IJMS22010165","journal-title":"Int J Mol Sci"},{"issue":"22","key":"4294_CR61","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1161\/CIRCULATIONAHA.112.101261","volume":"126","author":"AC Valbuena-Diez","year":"2012","unstructured":"Valbuena-Diez AC, Blanco FJ, Oujo B, Langa C, Gonzalez-Nunez M, Llano E, Pendas AM, Diaz M, Castrillo A, Lopez-Novoa JM, Bernabeu C (2012) Oxysterol-induced soluble endoglin release and its involvement in hypertension. Circulation 126(22):2612\u20132624. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.101261","journal-title":"Circulation"},{"issue":"6","key":"4294_CR62","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s11906-013-0400-1","volume":"15","author":"DE Henao","year":"2013","unstructured":"Henao DE, Saleem MA (2013) Proteinuria in preeclampsia from a podocyte injury perspective. Curr Hypertens Rep 15(6):600\u2013605. https:\/\/doi.org\/10.1007\/s11906-013-0400-1","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"4294_CR63","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nrneph.2012.291","volume":"9","author":"N NSachs","year":"2013","unstructured":"Sachs N, Sonnenberg A (2013) Cell-matrix adhesion of podocytes in physiology and disease. Nat Rev Nephrol 9(4):200\u2013210. https:\/\/doi.org\/10.1038\/nrneph.2012.291","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"4294_CR64","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ki.2014.17","volume":"86","author":"IM Craici","year":"2014","unstructured":"Craici IM, Wagner SJ, Weissgerber TL, Grande JP, Garovic VD (2014) Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int 86(2):275\u2013285. https:\/\/doi.org\/10.1038\/ki.2014.17","journal-title":"Kidney Int"},{"issue":"13","key":"4294_CR65","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1080\/14767058.2016.1219986","volume":"30","author":"N Cim","year":"2016","unstructured":"Cim N, Kurdoglu M, Ege S, Yoruk I, Yaman G, Yildizhan R (2016) An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia. J Matern Neonatal Med 30(13):1602\u20131607. https:\/\/doi.org\/10.1080\/14767058.2016.1219986","journal-title":"J Matern Neonatal Med"},{"key":"4294_CR66","doi-asserted-by":"publisher","first-page":"3027363","DOI":"10.1155\/2016\/3027363","volume":"2016","author":"C R\u01cedulescu","year":"2016","unstructured":"R\u01cedulescu C, Bac\u00e2rea A, Huanu A, Gabor R, Dobreanu M (2016) Placental growth factor, soluble fms-like tyrosine kinase 1, soluble endoglin, IL-6, and IL-16 as biomarkers in preeclampsia. Mediat Inflamm 2016:3027363. https:\/\/doi.org\/10.1155\/2016\/3027363","journal-title":"Mediat Inflamm"},{"key":"4294_CR67","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jtemb.2014.06.011","volume":"29","author":"VB Rezende","year":"2014","unstructured":"Rezende VB, Barbosa F, Palei AC, Cavalli RC, Tanus-Santos JE, Sandrim VC (2014) Correlations among antiangiogenic factors and trace elements in hypertensive disorders of pregnancy. J Trace Elem Med Biol 29:130\u2013135. https:\/\/doi.org\/10.1016\/j.jtemb.2014.06.011","journal-title":"J Trace Elem Med Biol"},{"issue":"5","key":"4294_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0097632","volume":"9","author":"LO Perucci","year":"2014","unstructured":"Perucci LO, Gomes KB, Freitas LG, Godoi LC, Ampoim PN, Pinheiro MB, Miranda AS, Texeira AL, Dusse LM, Sousa LP (2014) Soluble endoglin, transforming growth factor-beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PLoS ONE 9(5):1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0097632","journal-title":"PLoS ONE"},{"issue":"5","key":"4294_CR69","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/aogs.12366","volume":"93","author":"CM Tobinaga","year":"2014","unstructured":"Tobinaga CM, Torloni MR, Gueuvoghlanian-Silva BY, Pendeloski K, Akita PA, Sass N, Dahel S (2014) Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia. Acta Obstet Gynecol Scand 93(5):469\u2013476. https:\/\/doi.org\/10.1111\/aogs.12366","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"7","key":"4294_CR70","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","volume":"119","author":"CE Kleinrouweler","year":"2012","unstructured":"Kleinrouweler CE, Wiegerinck MMJ, Ris-Stalpers C, Bossuyt PMM, van der Post JAM, von Dadelszen P, Mol BWJ, Pajkrt E, EBM CONNECT Collaboration (2012) Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 119(7):778\u2013787. https:\/\/doi.org\/10.1111\/j.1471-0528.2012.03311.x","journal-title":"BJOG"},{"key":"4294_CR71","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejogrb.2014.09.027","volume":"182","author":"RE Allen","year":"2014","unstructured":"Allen RE, Rogozinska E, Cleverly K, Aquilina J, Thangaratinam S (2014) Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 182:194\u2013201. https:\/\/doi.org\/10.1016\/j.ejogrb.2014.09.027","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4294_CR72","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejogrb.2021.01.039","volume":"258","author":"G Margioula-Siarkou","year":"2021","unstructured":"Margioula-Siarkou G, Margioula-Siarkou C, Petousis S, Margaritis K, Alexandratou M, Dinas K, Sotiriadis A, Mavromatidis G (2021) Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 258:366\u2013381. https:\/\/doi.org\/10.1016\/j.ejogrb.2021.01.039","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"4294_CR73","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/00365513.2018.1516892","volume":"78","author":"LV Smirnov","year":"2018","unstructured":"Smirnov LV, Gryazeva IV, Vasileva MY, Krutetskaia IY et al (2018) New highly sensitive sandwich ELISA system for soluble endoglin quantification in different biological fluids. Scand J Clin Lab Invest 78(6):515\u2013523. https:\/\/doi.org\/10.1080\/00365513.2018.1516892","journal-title":"Scand J Clin Lab Invest"},{"issue":"8","key":"4294_CR74","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1291\/hypres.31.1541","volume":"31","author":"C Hirashima","year":"2008","unstructured":"Hirashima C, Ohkuchi A, Matsubara S, Suzuki H, Takahashi K, Usui R, Suzuki M (2008) Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. Hypertens Res 31(8):1541\u20131548. https:\/\/doi.org\/10.1291\/hypres.31.1541","journal-title":"Hypertens Res"},{"issue":"9","key":"4294_CR75","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/14712598.2017.1346607","volume":"17","author":"C Ollauri-Ib\u00e1\u00f1ez","year":"2017","unstructured":"Ollauri-Ib\u00e1\u00f1ez C, L\u00f3pez-Novoa JM, Pericacho M (2017) Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies. Expert Opin Biol Ther 17(9):1053\u20131063. https:\/\/doi.org\/10.1080\/14712598.2017.1346607","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"4294_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22010147","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu Y, Paauwe M, Nixon AB, Hawinkels LJAC (2021) Endoglin targeting: lessons learned and questions that remain. Int J Mol Sci 22(1):1\u201315. https:\/\/doi.org\/10.3390\/ijms22010147","journal-title":"Int J Mol Sci"},{"issue":"18","key":"4294_CR77","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1182\/blood-2017-01-763581","volume":"129","author":"KMC Dourado","year":"2017","unstructured":"Dourado KMC, Baik J, Oliveira VKP, Beltrame M, Yamamoto A, Theuer CP, Figueiredo CAV, Verneris MR, Perlingeiro RCR (2017) Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models. Blood 129(18):2526\u20132536. https:\/\/doi.org\/10.1182\/blood-2017-01-763581","journal-title":"Blood"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04294-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04294-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04294-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T02:33:12Z","timestamp":1673749992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04294-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4294"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04294-z","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. The present article does not involve intervention on a population of humans and\/or animals directly, it is a review of literature that gathers information from published articles.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. The present article does not involve intervention on a population of humans and\/or animals directly, it is a review of literature that gathers information from published articles.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. The present article does not involve intervention on a population of humans and\/or animals directly, it is a review of literature that gathers information from published articles.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}